Moustafa Elnewishy

Moustafa Elnewishy

Auto-generated profile, based on publicly available information

Moustafa Elnewishy

Epidemiological Cardiology Research Center (EPICARE), Department of Cardiovascular Medicine, Wake Forest University School of Medicine

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2024 in WFUMB Ultrasound Open
Verified
Journal Article
Open access
AEAnas M Elgenidy
Anas M Elgenidy
RORamez M. Odat
Ramez M. Odat
MHMohamed Marey Hesn
Mohamed Marey Hesn
AAAsmaa Abodaif
Asmaa Abodaif
MEMohamed S. Elgendy
Mohamed S. Elgendy
PWPaula Gamal Wassef
Paula Gamal Wassef
Introduction: Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder with unclear pathogenesis, characterized by diverse symptoms such as bloating, abdominal pain, and altered bowel habits. Medical imaging, particularly ultrasound, has gained importance in diagnosing and managing IBS due to its non-invasiveness and affordability. We aim to evaluate the utility of ultrasound (US) in diagnosing and monitoring IBS by assessing various aspects such as intestinal motility, gallbladder function, urinary bladder, gastric function, autonomic dysfunction, and vagus nerve assessment. Methods: Studies were collected from PubMed, Scopus, Cochrane, Embase, and the Web of Science. Eligible studies were selected based on the inclusion criteria. Data extraction covered study characteristics (such as country, US device type, patients, age, site of US evaluation, and dyspepsia) and the role of the US in bowel-wall thickness, sigmoid colon motility, gallbladder function, gastric function, autonomic dysfunction, and vagus nerve assessment. Results: Twenty studies were included, encompassing diverse ultrasound modalities and patient populations. Ultrasound showed promise in assessing bowel-wall thickness, sigmoid colon motility, gallbladder function, gastric function, autonomic dysfunction, and vagus nerve assessment in IBS patients. Notably, ultrasound demonstrated potential for distinguishing between IBS and inflammatory bowel disease (IBD) and aiding in disease prediction and severity assessment. Conclusion: This comprehensive review underscores the value of ultrasound in diagnosing and managing IBS, offering insights into its diverse applications and diagnostic accuracies across various aspects of gastrointestinal function. However, further research is warranted to address the limitations and optimize the diagnostic accuracy of ultrasound in IBS management.

12 September 2026 in medRxiv
Verified
Preprint
Open access
PDF file
AMAsem M Mohsen
Asem M Mohsen
MEMoustafa Elnewishy
Moustafa Elnewishy
TZTarek Zaho
Tarek Zaho
PCPatrick Cheon
Patrick Cheon
BBBrian C. Boursiquot
Brian C. Boursiquot
Elsayed Z SolimanElsayed Z Soliman
Elsayed Z Soliman
Background: Electrocardiographic markers of atrial cardiomyopathy (AtCM) are associated with adverse cardiovascular outcomes. Whether AtCM further refines cardiovascular disease (CVD) mortality risk across increasing cardiometabolic risk factor (CMRF) burden is unclear. Methods: We analyzed 7,083 adults free of baseline CVD. AtCM was defined by the presence of ≥1 ECG marker: prolonged P-wave duration ≥120 ms in lead II, abnormal P-wave axis outside 0-75, or deep terminal negativity of the P wave in V1 <-100 μV. CMRF burden was defined as the presence of 0, 1, or ≥2 of hypertension, diabetes, and obesity. CVD mortality was ascertained through December 31, 2006. Results: Among 7,083 participants (mean age 58 years and 48% men), CVD mortality rates increased progressively across the six combined exposure groups. In a multivariable adjusted Cox proportional hazard analysis, AtCM identified higher-risk subgroups within each CMRF burden category, with risk increasing progressively across combined exposure groups and highest among participants with ≥2 risk factors and AtCM (HR 2.25, 95% CI 1.75-2.87). In secondary analyses, a similar pattern was observed for individual CMRFs, with the combination of AtCM and hypertension, diabetes, or obesity conferring the highest risk compared with participants with neither condition (HR (95% CI): 1.58 (1.31-1.89); 2.08 (1.62-2.68); and 1.47 (1.19-1.82), respectively). Conclusions: ECG-defined AtCM refined CVD mortality risk across increasing CMRF burden. Individuals with both AtCM and multiple CMRFs had the highest risk. These findings support the potential role of ECG-based AtCM assessment as a scalable approach to improve cardiovascular risk stratification among individuals with CMRFs.